New hydrogel injection for knee osteoarthritis offers patients a return to mobility without surgery

Promotional feature A novel injectable treatment for knee osteoarthritis that harnesses non-biodegradable hydrogel technology – Arthrosamid® – was officially launched to the UK market at the British Orthopaedic Association (BOA)